New blood test could spot hidden cancers before symptoms start
NCT ID NCT06939049
First seen May 16, 2026 · Last updated May 25, 2026 · Updated 3 times
Summary
This study aimed to create a simple blood test to find markers of a process called epithelial-mesenchymal transition, which is linked to many cancers, especially breast and lung cancer. Researchers worked with 250 adults who had breast or lung cancer but had not yet started treatment. The goal was to develop a non-invasive way to detect cancer earlier and monitor how well treatments are working.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asl Lecce
Lecce, LECCE, 73100, Italy
Conditions
Explore the condition pages connected to this study.